In adults with post–COVID-19 conditions, a synbiotic preparation, SIM01, alleviated some symptoms at 6 mo

Keyphrases

• Placebo 100%
• Synbiotic Preparation 100%
• Hong Kong 66%
• COVID-19 Diagnosis 66%
• Patient Care 33%
• Medical Research 33%
• Health Research 33%
• Quantitative PCR 33%
• Adverse Events 33%
• Healthcare Professionals 33%
• Disease Prevention 33%
• Randomized Placebo-controlled Trial 33%
• Median Time 33%
• Bacterial Strains 33%
• Colony Forming Units 33%
• Ethnic Chinese 33%
• Centers for Disease Control 33%
• Gastrointestinal Surgery 33%
• Treatment Allocation 33%
• Probiotic Mixture 33%
• Vitamin C 33%
• Symptom-based 33%
• Oral Fluid 33%
• Immunocompromised Condition 33%
• Galacto-oligosaccharides 33%
• Longum 33%
• Research Fund 33%
• Rapid Antigen Test 33%
• Post-acute COVID-19 Syndrome 33%
• Adjudication Committee 33%
• Event Causality 33%
• Bifidobacterium Adolescentis 33%
• Bifida 33%
• Prince of Wales 33%
• Resistant Dextrin 33%
• Xylooligosaccharides 33%

Medicine and Dentistry

• Placebo 100%
• Synbiotic 100%
• COVID-19 50%
• Oral 50%
• Diseases 25%
• Patient Care 25%
• Infection 25%
• Adverse Event 25%
• Reverse Transcription Polymerase Chain Reaction 25%
• Prebiotics 25%
• Oligosaccharide 25%
• Medical Research 25%
• Gastrointestinal Surgery 25%
• Dextrin 25%
• Bifidobacterium adolescentis 25%
• Galactose Oligosaccharide 25%
• COVID-19 Diagnosis 25%
• Ascorbic Acid 25%